Over 30 years of experience in the identification, valuation, and remaining life analysis of intangible assets (IAs) and intellectual property (IP) as well as the appraisal of business enterprises and partial business interests. He has also assisted in matters involving fixed assets and real estate valuations.
Dr. Dandekar has worked on numerous engagements involving purchase price allocation for tax purposes as well as identification and valuation of IAs for financial reporting compliance purposes (ASC 805 / SFAS 141-R), and goodwill impairment testing (ASC 350 / SFAS 142). He has performed privately held business valuations for ESOP, dissenting shareholder resolution, non-qualified deferred compensation, marital dispute, etc.
He has performed valuations of various type of IAs, including in-process research and development, backlog, patented and proprietary technologies for several high-tech (semiconductor, telecom, FTTX, etc.) and pharma (pre-trial) clients. He led the technology valuation team in the fresh start accounting project for a major US automobile manufacturer and a silicon wafer manufacturer.
Dr. Dandekar has valued of patented technology and know-how related to power conversion, for potential buy out or licensing purposes. He has valued proprietary technologies (for food service products and pet foods) and their economic remaining lives for law firm in its representation of the acquirer in litigation against the IRS.
Dr. Dandekar has published several articles in industry journals and presented in industry seminars and symposiums as a subject matter expert in the areas related to IA and IP valuations. He has developed a module for the American Society of Appraisers' intangibles course. Dr. Dandekar has provided depositions and expert witness testimonies in state courts and in binding arbitration.